Blincyto
(blinatumomab)blinatumomab 0.035 MG Injection [Blincyto]
Dosage & administration
biomarker testing
Blincyto clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.
drug label
Blincyto prescribing information
financial assistance
Blincyto financial assistance options
Co-pay savings program
commercial only
Learn More
Foundation programs
under insured
no insurance
goverment insurance
65+
Learn More
patient education
Blincyto patient education
Getting started on Blincyto
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
Learn More
Other resources
Learn More
people also ask
Blincyto FAQs
How is the dosage of Blincyto?Blincyto is available in 1 dosages, including 35 mcg Injection
What does Blincyto treat?Blincyto treats Lymphoid Leukemia
What is Blincyto made of?Blincyto contains blinatumomab which is a Bispecific CD19-directed CD3-directed T Cell Engager
How Is Blincyto Administered?Blincyto is administered as a Injectable
What Are The Blincyto Mechanism Of Action?Blincyto mechanism of action is CD19-directed Antibody Interactions, CD3 Receptor Agonists or CD3-directed Antibody Interactions
FAQ Data Source